Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, August 25, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Life Sciences
Emilie Bodoin of Pure Lithium Honored as Trailblazing Woman of the Year at Volta Foundation Awards
Life Sciences Times
-
June 27, 2025
0
Biotech
Milwaukee-Based Biotech Firm UP Oncolytics Secures State Grant to Advance Brain Cancer Therapy
Life Sciences Times
-
June 26, 2025
0
Biotech
Epicutis Launches Hydrobiome Mist to Support Skin Barrier and Microbiome Health
Life Sciences Times
-
June 26, 2025
0
Legal
Calibre One Adds Jed Donnelly as Partner to Bolster Life Sciences and Biopharma Expertise
Life Sciences Times
-
June 26, 2025
0
Healthcare
Sanofi Awards Over $1 Million in Grants to Support Community Health Programs Across Massachusetts
Life Sciences Times
-
June 26, 2025
0
Pharma
Pfizer Reports Strong Phase 3 Results for Hemophilia Drug HYMPAVZI
Life Sciences Times
-
June 26, 2025
0
Venture Capital
Vellum Health Raises Series A Funding, Launches Mobile IV Care Platform for Bedside Treatment
Life Sciences Times
-
June 26, 2025
0
Medtech
Scanfil to Manufacture Liquid Instruments’ Moku Platform in Australia, Strengthening Local Tech Supply Chain
Life Sciences Times
-
June 26, 2025
0
Technology
Global Health Groups Establish First Joint Ethical Principle on AI Use in Healthcare
Life Sciences Times
-
June 26, 2025
0
Pharma
Metabolics Pharma Reports Early Positive Results for Experimental Obesity and Diabetes Drug
Life Sciences Times
-
June 26, 2025
0
1
...
34
35
36
...
710
Page 35 of 710
Most Popular
ProVerum Raises $80 Million in Series B to Advance Commercialization of BPH Treatment
August 25, 2025
Cambrex Expands Peptide Manufacturing Capabilities at Waltham, Massachusetts Facility
August 25, 2025
Merz Therapeutics Begins Phase III Trials of XEOMIN® for Migraine Prevention
August 25, 2025
Sonoma Biotherapeutics Appoints Lisa Taylor Ash as Chief Legal Officer
August 25, 2025
Load more
Recent Comments
Recent Comments